Loading…
Prescription Reduction in Costs for Everyone (PRICE) Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
52pct
7d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the President, with respect to offering one or more Medicare-operated prescription drug plan options, to: (1) negotiate prices with drug manufacturers, and (2) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to other prescription drug plans. The President must report to Congress biannually on negotiations conducted by the President to achieve lower prices for Medicare beneficiaries.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2018 · third_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. S 469 Affordable and Safe Prescription Drug Importation Act S 2553 Know the Lowest Price Act of 2018 -- prohibits health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals S 2554 Patient Right to Know Drug Prices Act -- ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees S 2645 To establish a demonstration program under which the Drug Enforcement Administration provides grants to certain States to enable those States to increase participation in drug take-back programs. HR 5041 To amend the Controlled Substances Act to authorize the employees of a hospice program to handle controlled substances lawfully in the possession of a deceased hospice patient for the purpose of disposal.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. S 469 Affordable and Safe Prescription Drug Importation Act S 2553 Know the Lowest Price Act of 2018 -- prohibits health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals S 2554 Patient Right to Know Drug Prices Act -- ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees S 2645 To establish a demonstration program under which the Drug Enforcement Administration provides grants to certain States to enable those States to increase participation in drug take-back programs. HR 5041 To amend the Controlled Substances Act to authorize the employees of a hospice program to handle controlled substances lawfully in the possession of a deceased hospice patient for the purpose of disposal.
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017 S 469 Affordable and Safe Prescription Drug Importation Act S 2553 Know the Lowest Price Act of 2018 -- prohibits health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals S 2554 Patient Right to Know Drug Prices Act -- ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017 S 469 Affordable and Safe Prescription Drug Importation Act
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017 S 469 Affordable and Safe Prescription Drug Importation Act
Client expense: $34,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245/S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. HR 2376 Drug Diversion and Counterfeit Crackdown Act of 2017
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Consumer Issues/Safety/Products
HR 1316 To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes. S 495 Medical Innovation Prize Fund Act HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 HR 1703 Medical Product Communications Act of 2017 S 771 Improving Access To Affordable Prescription Drugs Act HR 1775 Prescription Reduction in Costs for Everyone (PRICE) Act of 2017 HR 1776 Improving Access To Affordable Prescription Drugs Act HR 1480 Safe and Affordable Drugs from Canada Act of 2017 HR 1245, S 469 To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE